A股異動丨新開普(300248.SZ)跌逾7% 澄清稱目前公司未涉及虛擬數字人領域
格隆匯1月5日丨新開普(300248.SZ)跌逾7%,報15.5元,總市值75億元。新開普昨日盤後發佈異動公吿,目前,公司為高校、K12、中職、企業等細分業務領域客户提供支付平台和收款設備的整體解決方案,實現數字人民幣的交易應用場景,但目前數字人民幣試點城市較少,在公司收入中佔比很低。公司於2021年10月增資上海渲圖,持有其51%的股權,有助於公司藉助上海渲圖的VR技術及經驗,可以優化面向高校市場的虛擬現實雲平台,提升公司智慧校園綜合解決方案的競爭力。但目前相關業務還處於市場拓展階段,在公司收入中佔比很低。目前,公司未涉及虛擬數字人、遊戲與社交領域。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.